Reneo Pharmaceuticals (RPHM) Stock Chart & Stock Price History → Pentagon contract could send this $2 AI stock soaring (From Behind the Markets) (Ad) Free RPHM Stock Alerts $1.68 -0.02 (-0.89%) (As of 04:18 PM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Reneo Pharmaceuticals Stock Price Performance5 Day Performance-4.83%1 Month Performance+0.90%3 Month Performance-0.30%6 Month Performance-78.47%Year-To-Date Performance+4.69%1 Year Performance-84.05% Receive RPHM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Reneo Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Behind the MarketsPentagon contract could send this $2 AI stock soaringWhenever the Department of Defense awards a major AI contract... Early investors could see dramatic returns virtually overnight. That's how my readers were able to cash in gains like 133% in just four months on C3.ai...Get all the info here >>> RPHM Stock Chart for Tuesday, April, 23, 2024 RPHM Chart by TradingView Reneo Pharmaceuticals Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/22/2024$1.74$1.69-2.87%$1.74$1.65181,894 shs$56.48 million04/19/2024$1.76$1.74-1.14%$1.75$1.7082,987 shs$58.15 million04/18/2024$1.77$1.76-0.56%$1.78$1.7076,424 shs$58.82 million04/17/2024$1.65$1.77+7.27%$1.92$1.64348,987 shs$59.15 million04/16/2024$1.66$1.65-0.60%$1.70$1.6348,695 shs$55.14 million04/15/2024$1.73$1.66-4.05%$1.75$1.64185,965 shs$55.48 million Get the Latest News and Ratings for RPHM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Reneo Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 04/12/2024$1.70$1.73+1.76%$1.76$1.7042,664 shs$57.82 million04/11/2024$1.71$1.70-0.58%$1.72$1.6865,091 shs$56.81 million04/10/2024$1.70$1.71+0.59%$1.71$1.6756,031 shs$57.15 million04/09/2024$1.68$1.70+1.19%$1.72$1.6843,653 shs$56.81 million04/08/2024$1.71$1.68-1.75%$1.71$1.6847,814 shs$56.15 million04/05/2024$1.73$1.71-1.16%$1.75$1.6689,328 shs$57.15 million04/04/2024$1.71$1.73+1.17%$1.73$1.6978,042 shs$57.82 million04/03/2024$1.71$1.71$1.74$1.6779,871 shs$57.15 million04/02/2024$1.70$1.71+0.59%$1.71$1.6786,279 shs$56.96 million04/01/2024$1.66$1.70+2.41%$1.70$1.63165,941 shs$56.63 million03/29/2024$1.66$1.66$1.68$1.64104,273 shs$55.30 million03/28/2024$1.65$1.66+0.61%$1.68$1.64104,273 shs$55.30 million03/27/2024$1.65$1.65$1.71$1.6447,064 shs$54.96 million03/26/2024$1.67$1.65-1.20%$1.73$1.6470,908 shs$54.96 million03/25/2024$1.66$1.67+0.60%$1.71$1.6375,256 shs$55.63 million03/22/2024$1.69$1.66-1.78%$1.70$1.6367,545 shs$55.30 million03/21/2024$1.66$1.69+1.81%$1.69$1.6394,189 shs$56.29 million03/20/2024$1.65$1.66+0.61%$1.67$1.6288,736 shs$55.30 million03/19/2024$1.64$1.65+0.61%$1.67$1.63112,745 shs$54.96 million03/18/2024$1.66$1.64-1.20%$1.66$1.62170,550 shs$54.63 million03/15/2024$1.60$1.66+3.75%$1.67$1.57272,907 shs$55.30 million03/14/2024$1.61$1.60-0.62%$1.62$1.58649,466 shs$53.30 million03/13/2024$1.60$1.61+0.63%$1.65$1.55331,632 shs$53.63 million03/12/2024$1.61$1.60-0.62%$1.62$1.58230,276 shs$53.30 million03/11/2024$1.66$1.61-3.01%$1.66$1.61104,393 shs$53.63 million03/08/2024$1.64$1.66+1.22%$1.70$1.62279,248 shs$55.30 million03/07/2024$1.62$1.64+1.23%$1.66$1.61159,972 shs$54.63 million03/06/2024$1.64$1.62-1.22%$1.65$1.6286,569 shs$53.96 million03/05/2024$1.63$1.64+0.61%$1.66$1.62116,536 shs$54.63 million03/04/2024$1.64$1.63-0.61%$1.65$1.61176,079 shs$54.30 million03/01/2024$1.65$1.64-0.61%$1.67$1.6198,584 shs$54.63 million02/29/2024$1.62$1.65+1.85%$1.67$1.61176,340 shs$54.97 million02/28/2024$1.66$1.62-2.41%$1.66$1.6278,448 shs$53.96 million02/27/2024$1.64$1.66+1.22%$1.70$1.66152,230 shs$55.30 millionPentagon contract could send this $2 AI stock soaring (Ad)Whenever the Department of Defense awards a major AI contract... Early investors could see dramatic returns virtually overnight. That's how my readers were able to cash in gains like 133% in just four months on C3.ai...Get all the info here >>>02/26/2024$1.61$1.64+1.86%$1.66$1.61310,816 shs$54.63 million02/23/2024$1.63$1.61-1.23%$1.66$1.61379,835 shs$53.63 million02/22/2024$1.62$1.63+0.62%$1.65$1.57428,296 shs$54.30 million02/21/2024$1.64$1.62-1.22%$1.66$1.60377,975 shs$53.96 million02/20/2024$1.65$1.64-0.61%$1.66$1.62201,207 shs$54.63 million02/19/2024$1.65$1.65$1.68$1.64208,500 shs$54.97 million02/16/2024$1.67$1.65-1.20%$1.68$1.64208,569 shs$54.96 million02/15/2024$1.67$1.67$1.72$1.65106,633 shs$55.63 million02/14/2024$1.65$1.67+1.21%$1.68$1.6497,731 shs$55.63 million02/13/2024$1.70$1.65-2.94%$1.69$1.64254,092 shs$54.96 million02/12/2024$1.74$1.70-2.30%$1.85$1.65322,701 shs$56.63 million02/09/2024$1.65$1.74+5.45%$1.76$1.64604,855 shs$57.96 million02/08/2024$1.64$1.65+0.61%$1.66$1.60192,375 shs$54.96 million02/07/2024$1.65$1.64-0.61%$1.65$1.61241,286 shs$54.63 million02/06/2024$1.64$1.65+0.61%$1.67$1.60238,218 shs$54.96 million02/05/2024$1.59$1.64+3.14%$1.66$1.58437,240 shs$54.63 million02/02/2024$1.64$1.59-3.05%$1.66$1.59516,001 shs$52.96 million02/01/2024$1.64$1.64$1.67$1.64178,852 shs$54.63 million01/31/2024$1.65$1.64-0.61%$1.66$1.63458,196 shs$54.63 million01/30/2024$1.68$1.65-1.79%$1.69$1.62338,792 shs$54.96 million01/29/2024$1.65$1.68+1.82%$1.71$1.63497,515 shs$55.96 million01/26/2024$1.69$1.65-2.37%$1.70$1.64351,449 shs$54.97 million01/25/2024$1.65$1.69+2.42%$1.70$1.62352,509 shs$56.29 million01/24/2024$1.68$1.65-1.79%$1.68$1.62436,367 shs$54.96 million01/23/2024$1.60$1.68+5.33%$1.69$1.58709,860 shs$55.96 million01/22/2024$1.61$1.60-0.93%$1.61$1.57408,773 shs$53.13 million Related Companies: VAXX Stock Chart FIXX Stock Chart IMRX Stock Chart KZR Stock Chart SCYX Stock Chart GMTX Stock Chart GANX Stock Chart VHAQ Stock Chart CKPT Stock Chart HCWB Stock Chart Receive RPHM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Reneo Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:RPHM) was last updated on 4/23/2024 by MarketBeat.com Staff From Our Partnerstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersMan Who Predicted 2008: “This Will be Worse.”AltimetryExposed: How Big Banks Plan to Chain Your Wealth with Digital DollarsGoldenCrest MetalsIs Tesla going out of business?DTI Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Reneo Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.